Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy

Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy

Introduction. We are aware of the risk of late virological relapse (LVR) years after sustained viral response (SVR) by pegylated interferon and ribavirin alfa (PegIFN + RBV) of chronic hepatitis C viral (HCV) infection. We presented three patients with LVR, treated by PegIFN and ribavirin 5 years...

Full description

Bibliographic Details
Main Authors: Ružić Maja, Fabri Milotka, Preveden Tomislav, Bačulov Katarina, Pete Maria, Stojšin Anja
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2018-01-01
Series:Vojnosanitetski Pregled
Subjects:
chronic hepatitis C
interferon alfa-2b
ribavirin
treatment outcome
recurrence
autoimmune diseases
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501700015R.pdf

Similar Items

Similar Items